TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Urologix AB
Closing information (x1000 SEK)
Closing information | 2024/08 | 2023/08 | 2022/08 |
Turnover |
6,952
|
7,621 | |
Financial expenses |
0
![]() |
0 | |
Earnings before taxes |
1,692
|
2,013 | |
EBITDA |
1,823
|
2,052 | |
Total assets |
2,104
|
2,390 | |
Current assets |
1,227
|
2,171 | |
Current liabilities |
517
|
575 | |
Equity capital |
1,587
|
1,815 | |
- share capital |
100
![]() |
100 | |
Employees (average) |
4
|
5
![]() |
5 |
Financial ratios
Fiscal year | 2024/08 | 2023/08 | 2022/08 |
Solvency |
75.4%
|
75.9% | |
Turnover per employee |
1,390
|
1,524 | |
Profit as a percentage of turnover |
24.3%
|
26.4% | |
Return on assets (ROA) |
80.4%
|
84.2% | |
Current ratio |
237.3%
|
377.6% | |
Return on equity (ROE) |
106.6%
|
110.9% | |
Change turnover |
-669
|
514 | |
Change turnover % |
0%
|
-9%
|
7% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-20%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/08 | 2023/08 | 2022/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.